1-Ethyl-2,3,3-trimethyl-3H-indol-1-ium-5-sulfonate, 95%, 100mg

tert-Butyl (10-bromodecyl)carbamate, 95%, 250mg

N-(1,3-Dihydroxy-2-(hydroxymethyl)propan-2-yl)acrylamide, 95.0%, 25g

3-(6-Chloro-3-oxo-1H-pyrrolo[3,4-c]pyridin-2(3H)-yl)piperidine-2,6-dione, 98%, 1g

tert-Butyl propiolate, 95.0%, 25g

(1R*,4R*)-N1-(3-Fluorobenzyl)cyclohexane-1,4-diamine dihydrochloride, 1g

Valsartan>98.0%(HPLC)(T)5g

3-(2-Chloro-10H-phenothiazin-10-yl)-N,N-dimethylpropan-1-amine, 95.0%, 1g

Dimethoxymethane>98.0%(GC)500mL

trans-cinnamaldehyde, min 98.5%, for synthesis, 250 ml, glass packaging

2-[(Prop-2-ynyloxy)methyl]oxirane, 95.0%, 25g

4-Bromo-N-(4-bromophenyl)-N-(4-(sec-butyl)phenyl)aniline, 97%, 100mg

4-Methoxyisobenzofuran-1(3H)-one, 95.0%, 250mg